300 related articles for article (PubMed ID: 9300746)
41. Results of radiation therapy in early glottic carcinoma (T1, T2 N0).
Stein M; Rosenblatt E; Kuten A; Cohen Y
J Surg Oncol; 1989 Mar; 40(3):173-6. PubMed ID: 2918722
[TBL] [Abstract][Full Text] [Related]
42. Predicting the local outcome of glottic squamous cell carcinoma after definitive radiation therapy: value of computed tomography-determined tumour parameters.
Hermans R; Van den Bogaert W; Rijnders A; Doornaert P; Baert AL
Radiother Oncol; 1999 Jan; 50(1):39-46. PubMed ID: 10225556
[TBL] [Abstract][Full Text] [Related]
43. [Stage 1 glottic laryngeal carcinoma: observations on 76 cases treated with transcutaneous radiotherapy].
Bonetta A; Morrica B; Zingoni A; Caraffini B
Radiol Med; 1996 Jun; 91(6):802-4. PubMed ID: 8830370
[TBL] [Abstract][Full Text] [Related]
44. Prognostic factors in elderly patients with T1 glottic cancer treated with radiotherapy.
Mucha-Małecka A; Małecki K; Amrogowicz N; Biesaga B; Modrzejewski M
Sci Rep; 2021 Sep; 11(1):17717. PubMed ID: 34489495
[TBL] [Abstract][Full Text] [Related]
45. Salvage surgery after radiotherapy failure in T1-T2 squamous cell carcinoma of the glottic larynx.
McLaughlin MP; Parsons JT; Fein DA; Stringer SP; Cassisi NJ; Mendenhall WM; Million RR
Head Neck; 1996; 18(3):229-35. PubMed ID: 8860763
[TBL] [Abstract][Full Text] [Related]
46. Results of definitive radiotherapy in T1 and T2 glottic carcinoma: Institute of Rotary Cancer Hospital experience.
Mohanti BK; Tandon DA; Bahadur S; Rath GK; Tanwar RK; Lal P; Biswal BM
Australas Radiol; 1996 Aug; 40(3):287-90. PubMed ID: 8826737
[TBL] [Abstract][Full Text] [Related]
47. The influence of some factors on local control of early glottic cancer.
Krawczyk J; Svoboda V; Foster L
Clin Oncol (R Coll Radiol); 1991 Nov; 3(6):330-4. PubMed ID: 1742232
[TBL] [Abstract][Full Text] [Related]
48. Radiation therapy of glottic carcinoma: Peter MacCallum Cancer Institute experience.
Guiney M; Smith J; Hughes P; Narayan K
Aust N Z J Surg; 1992 Aug; 62(8):622-7. PubMed ID: 1642583
[TBL] [Abstract][Full Text] [Related]
49. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiation therapy: relationship of dose-fractionation factors to local control and complications.
Mendenhall WM; Parsons JT; Million RR; Fletcher GH
Int J Radiat Oncol Biol Phys; 1988 Dec; 15(6):1267-73. PubMed ID: 3143690
[TBL] [Abstract][Full Text] [Related]
50. Early glottic cancer: the influence of primary treatment on voice preservation.
Lesnicar H; Smid L; Zakotnik B
Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1025-32. PubMed ID: 8985023
[TBL] [Abstract][Full Text] [Related]
51. A critical review of radiotherapy in the management of T1 glottic carcinoma.
Morris MR; Canonico D; Blank C
Am J Otolaryngol; 1994; 15(4):276-80. PubMed ID: 7978026
[TBL] [Abstract][Full Text] [Related]
52. [Place of iridium 192 implantation in irradiation of T1-T2 squamous cell carcinoma of the velopharyngeal arch].
Mazeron JJ; Belkacemi Y; Simon JM; Le Péchoux C; Martin M; Haddad E; Piedbois P; Calitchi E; Strunski W; Peynègre R; Le Bourgeois JP; Pierquin B
Bull Cancer Radiother; 1996; 83(1):47-53. PubMed ID: 8679281
[TBL] [Abstract][Full Text] [Related]
53. Dose, time, and fraction size issues for late effects in head and neck cancers.
Taylor JM; Mendenhall WM; Lavey RS
Int J Radiat Oncol Biol Phys; 1992; 22(1):3-11. PubMed ID: 1727126
[TBL] [Abstract][Full Text] [Related]
54. Prognostic factors of local control after radiotherapy in T1 glottic and supraglottic carcinoma of the larynx.
Carl J; Andersen LJ; Pedersen M; Greisen O
Radiother Oncol; 1996 Jun; 39(3):229-33. PubMed ID: 8783399
[TBL] [Abstract][Full Text] [Related]
55. Primary radiotherapy for glottic laryngeal carcinoma stage I and II. A retrospective study with special regard to failure patterns.
Turesson I; Sandberg N; Mercke C; Johansson KA; Sandin I; Wallgren A
Acta Oncol; 1991; 30(3):357-62. PubMed ID: 2036247
[TBL] [Abstract][Full Text] [Related]
56. Hypofractionation reduces the therapeutic ratio in early glottic carcinoma.
Harrison D; Crennan E; Cruickshank D; Hughes P; Ball D
Int J Radiat Oncol Biol Phys; 1988 Aug; 15(2):365-72. PubMed ID: 3403317
[TBL] [Abstract][Full Text] [Related]
57. Primary radiotherapy of T1 and T2 glottic carcinoma--analysis of treatment results and prognostic factors in 223 patients.
Klintenberg C; Lundgren J; Adell G; Tytor M; Norberg-Spaak L; Edelman R; Carstensen JM
Acta Oncol; 1996; 35 Suppl 8():81-6. PubMed ID: 9073052
[TBL] [Abstract][Full Text] [Related]
58. P53 overexpression is associated with bulky tumor and poor local control in T1 glottic cancer.
Narayana A; Vaughan AT; Kathuria S; Fisher SG; Walter SA; Reddy SP
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):21-6. PubMed ID: 10656367
[TBL] [Abstract][Full Text] [Related]
59. Management of Tis, T1, and T2 squamous cell carcinoma of the glottic larynx.
Mendenhall WM; Parsons JT; Stringer SP; Cassisi NJ
Am J Otolaryngol; 1994; 15(4):250-7. PubMed ID: 7978023
[No Abstract] [Full Text] [Related]
60. Radiation therapy in the treatment of early glottic carcinoma: the experience of Villejuif.
Lusinchi A; Dube P; Wibault P; Kunkler I; Luboinski B; Eschwege F
Radiother Oncol; 1989 Aug; 15(4):313-9. PubMed ID: 2798936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
